Active Caspofungin

DRUG2 trials

Sponsors

Pfizer

Conditions

CandidiasisFungemiaNeutropenia

Phase 3

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

TerminatedNCT00806351

PfizerCandidiasis, Fungemia, Neutropenia

Start: 2009-08-31End: 2011-10-31Updated: 2012-12-20

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

TerminatedNCT00805740

PfizerCandidiasis, Fungemia

Start: 2009-04-30End: 2012-06-30Updated: 2013-08-01

Related Papers

Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies.

2021-04-236 citations

Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.

2019-07-0616 citations

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.

2017-08-0120 citations

Anidulafungin for the treatment of candidaemia caused by<i>Candida parapsilosis</i>: Analysis of pooled data from six prospective clinical studies

Mycoses2017-06-0921 citations